Learn

Early-stage type 1 diabetes (T1D) is a critical yet poorly understood phase preceding clinical diagnosis. With 90% of diagnoses occurring without a family history, many individuals progress silently through islet autoimmunity until presenting with life-threatening diabetic ketoacidosis (DKA).   This webinar provides a case-based approach to navigating the GP's role in early identification and shared care. ''

Using a single case study followed across key decision points, clinical experts will guide you through pre-test counselling, interpreting islet autoantibodies, and applying the international three-stage framework. You will learn to identify high-risk phenotypes, establish evidence-based monitoring cadences, and recognise urgent "red flags" for specialist referral. The session also explores emerging disease-modifying therapies and practical strategies to reduce diagnostic delay, equipping you to support families with clarity and confidence.

Learning Outcomes

1. Apply a structured GP approach to early-stage T1D across key clinical decision points to guide when to test, how to counsel, and when to refer
2. Interpret autoantibody and baseline glycaemic results in context, recognising which findings require routine referral, urgent escalation, or ongoing shared care, and avoiding common management gaps after results are returned
3. Support patients and families once specialist care is established, including communicating risk, managing uncertainty and anxiety, and responding appropriately to questions and concerns.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.